CAMBRIDGE, MA, September 7, 2016 -- The CEO of Aurora BioPharma, Inc., Robert Brooks, will attend the Rodman & Renshaw 18th Annual Global Investment Conference being held at the New York Palace Hotel in New York City on September 11 - 13, 2016. The conference is expected to attract an audience of 2,000 attendees from the financial, investment and corporate arenas. Keynote Speakers are The Right Honourable Sir John Major KG CH, former Prime Minister of the United Kingdom and Jeb Bush, 43rd Governor of Florida.
Aurora BioPharma is a biotechnology company, revolutionizing the way we will treat cancer in the future. After 50 years of surgery, radiation and chemotherapy, cancer rates are still expected to double in the next 15 years. Medicine has a new weapon, genetically reprogramming the immune system into an elite killer army. Already three companies involved in genetically engineered Chimeric Antigen Receptor (CAR) T therapy, have been awarded Breakthrough Therapy Designation by the FDA for showing up to 90% remissions or nearly a "cure" in leukemia and other liquid tumors. Aurora has shown in a human Phase I/II trial with Glioblastoma, the most lethal brain cancer, nearly double the survival of a $1 Billion drug without the side effects. Glioblastoma claimed the lives of Senator Ted Kennedy and Vice President Biden's son, and many others.
Candace Cobos
Aurora BioPharma, Inc.
Tel: (617) 674-7718 - Fax: (617) 674-7701
candace.cobos@aurora-biopharma.com
SOURCE Aurora BioPharma, Inc.